Inhibikase Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.6k | 1.7k | 2.16 |
| 2023-09-30 | $2.3k | 1.7k | 1.39 |
| 2023-06-30 | $6.0k | 1.7k | 3.61 |